FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q49142843> ?p ?o ?g. }

• Q49142843 description "2015 nî lūn-bûn" @default.
• Q49142843 description "2015 թվականի մարտի 4-ին հրատարակված գիտական հոդված" @default.
• Q49142843 description "2015年の論文" @default.
• Q49142843 description "2015年学术文章" @default.
• Q49142843 description "2015年学术文章" @default.
• Q49142843 description "2015年学术文章" @default.
• Q49142843 description "2015年学术文章" @default.
• Q49142843 description "2015年学术文章" @default.
• Q49142843 description "2015年学术文章" @default.
• Q49142843 description "2015年學術文章" @default.
• Q49142843 description "2015年學術文章" @default.
• Q49142843 description "2015年學術文章" @default.
• Q49142843 description "2015年學術文章" @default.
• Q49142843 description "2015年學術文章" @default.
• Q49142843 description "2015년 논문" @default.
• Q49142843 description "article científic" @default.
• Q49142843 description "article scientific" @default.
• Q49142843 description "article scientifique" @default.
• Q49142843 description "articol științific" @default.
• Q49142843 description "articolo scientifico" @default.
• Q49142843 description "artigo científico" @default.
• Q49142843 description "artigo científico" @default.
• Q49142843 description "artigo científico" @default.
• Q49142843 description "artikel ilmiah" @default.
• Q49142843 description "artikull shkencor" @default.
• Q49142843 description "artikulong pang-agham" @default.
• Q49142843 description "artykuł naukowy" @default.
• Q49142843 description "artículo científico publicado en 2015" @default.
• Q49142843 description "artículu científicu" @default.
• Q49142843 description "bilimsel makale" @default.
• Q49142843 description "bài báo khoa học" @default.
• Q49142843 description "naučni članak" @default.
• Q49142843 description "scienca artikolo" @default.
• Q49142843 description "scientific article published on 4 March 2015" @default.
• Q49142843 description "scientific article published on 4 March 2015" @default.
• Q49142843 description "scientific article published on 4 March 2015" @default.
• Q49142843 description "teaduslik artikkel" @default.
• Q49142843 description "tieteellinen artikkeli" @default.
• Q49142843 description "tudományos cikk" @default.
• Q49142843 description "vedecký článok" @default.
• Q49142843 description "vetenskaplig artikel" @default.
• Q49142843 description "videnskabelig artikel" @default.
• Q49142843 description "vitenskapelig artikkel" @default.
• Q49142843 description "vitskapeleg artikkel" @default.
• Q49142843 description "vědecký článek" @default.
• Q49142843 description "wetenschappelijk artikel" @default.
• Q49142843 description "wissenschaftlicher Artikel" @default.
• Q49142843 description "επιστημονικό άρθρο" @default.
• Q49142843 description "мақолаи илмӣ" @default.
• Q49142843 description "наукова стаття, опублікована в березні 2015" @default.
• Q49142843 description "научна статия" @default.
• Q49142843 description "научная статья" @default.
• Q49142843 description "научни чланак" @default.
• Q49142843 description "научни чланак" @default.
• Q49142843 description "מאמר מדעי" @default.
• Q49142843 description "مقالة علمية نشرت في 4 مارس 2015" @default.
• Q49142843 description "৪ মার্চ ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q49142843 description "บทความทางวิทยาศาสตร์" @default.
• Q49142843 description "სამეცნიერო სტატია" @default.
• Q49142843 name "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 name "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 type Item @default.
• Q49142843 label "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 label "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 prefLabel "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 prefLabel "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 P1433 Q49142843-3837A4EB-2A93-4905-B54D-EF27FA6DCDA1 @default.
• Q49142843 P1476 Q49142843-D3A051C6-F8FF-4EFA-B760-29D31FBF2665 @default.
• Q49142843 P2093 Q49142843-06C37E53-B65A-4BB6-8D53-307718B46E97 @default.
• Q49142843 P2093 Q49142843-30795F04-BC7C-4A61-A22F-B26DC366FEFA @default.
• Q49142843 P2093 Q49142843-6E7E6D78-A9FF-4CFA-9926-2E42467F1B73 @default.
• Q49142843 P2093 Q49142843-F251C6C7-1E66-4B1D-9612-F96F1416CAE0 @default.
• Q49142843 P2860 Q49142843-1C4A1A43-23EB-4464-98A0-329B3F6F659B @default.
• Q49142843 P2860 Q49142843-5533E15A-CC1A-4417-8634-AEFAE1097EB4 @default.
• Q49142843 P2860 Q49142843-62A2701D-903F-47AD-9FC4-85A405117F41 @default.
• Q49142843 P2860 Q49142843-C085596B-B719-4EC6-9918-379017D14CA7 @default.
• Q49142843 P304 Q49142843-06D8EF17-255C-40EA-8C91-6DA172E41936 @default.
• Q49142843 P31 Q49142843-0B1AC707-F29E-4689-A516-2EDDD3CB9EE9 @default.
• Q49142843 P356 Q49142843-54148087-D6D3-46B7-AD80-B635492D1697 @default.
• Q49142843 P407 Q49142843-34F8646A-E116-4FED-8508-90C070667710 @default.
• Q49142843 P433 Q49142843-CD0887C8-0D40-4719-8806-99DE32E86973 @default.
• Q49142843 P478 Q49142843-29466B5F-CB0C-4F65-9456-2219658D9687 @default.
• Q49142843 P50 Q49142843-1C9371E8-CB71-4D18-82E6-5D5183B1B0D7 @default.
• Q49142843 P50 Q49142843-654B862E-C948-4BD9-A97C-3DEC6E08512F @default.
• Q49142843 P50 Q49142843-6d779bbb-71a3-4ed6-9865-8c3c0cc6199b @default.
• Q49142843 P577 Q49142843-B5428135-D478-4CB6-BFAD-A3AFDA398A72 @default.
• Q49142843 P5875 Q49142843-5E3B03C0-586D-45D6-A0D6-6896B489BE03 @default.
• Q49142843 P698 Q49142843-35AB6C4B-D881-4DDF-807C-643314955EAF @default.
• Q49142843 P921 Q49142843-CCAF5F78-F35C-4451-B11B-CFCC94CDC4A8 @default.
• Q49142843 P921 Q49142843-D7645DAA-8939-4884-ACB8-D10A625E5640 @default.
• Q49142843 P356 GFV050 @default.
• Q49142843 P698 25928337 @default.
• Q49142843 P1433 Q15710302 @default.
• Q49142843 P1476 "Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement." @default.
• Q49142843 P2093 "Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) working group and the European Renal Best Practice (ERBP) advisory board" @default.
• Q49142843 P2093 "Chronic Kidney Disease-Mineral Bone Disease CKD-MBD working group and the European Renal Best Practice ERBP advisory board" @default.
• Q49142843 P2093 "David Goldsmith" @default.
• Q49142843 P2093 "Marc Vervloet" @default.
• Q49142843 P2860 Q26851487 @default.
• Q49142843 P2860 Q35146504 @default.

• next